Publications by authors named "Dominique Genet"

Claim this Profile
M
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Valérie Boige, Hélène Blons, Eric François, Meher Ben Abdelghani, Jean-Marc Phelip, Dominique Genet

JAMA Netw Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Bernadette de Rauglaudre, Camille Sibertin-Blanc, Aurélie Fabre, Karine Le Malicot, Jaafar Bennouna, Dominique Genet

Ther Adv Med Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Alexandra Bizot, Maryam Karimi, Elie Rassy, Pierre Etienne Heudel, Christelle Levy, Dominique Genet

Br J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort.
Jean-Philippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux

Future Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions.
Stéphane Rossat, Hervé Perrier, Marine Lefevre, Christophe Louvet, Nathalie Le Berre, Dominique Genet

Pathol Oncol Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Anthony Dohan, Benoit Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Dominique Genet

Gut· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of PONDx, a prospective multicenter study of the Oncotype DX breast cancer assay: Real-life utilization and decision impact in French clinical practice.
Elsa Curtit, Jean-Michel Vannetzel, Jean-Claude Darmon, Sophie Roche, Hugues Bourgeois, Dominique Genet

Breast· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).
Thomas Aparicio, Francois Ghiringhelli, Valérie Boige, Karine Le Malicot, Julien Taieb, Dominique Genet

J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.
Thomas Aparicio, Dany Gargot, Laurent Teillet, Emilie Maillard, Dominique Genet

Eur J Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

Ann Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Jacques Monteil, Antoine Maubon, Sophie Leobon, Sonia Roux, Benoit Marin, Dominique Genet

Anticancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer.
Pasquale F Innominato, Christian Focan, Thierry Gorlia, Thierry Moreau, Carlo Garufi, Dominique Genet

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.
Valérie Le Brun-Ly, Jean Martin, Laurence Venat-Bouvet, Nicole Darodes, Jean-Luc Labourey, Dominique Genet

Oncology· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.
Bruno Coudert, Christian Focan, Dominique Genet, Sylvie Giacchetti, Frédérique Cvickovic

Chronobiol Int· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
Fabio Efficace, Pasquale F Innominato, Georg Bjarnason, Corneel Coens, Yves Humblet, Dominique Genet

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Logistic regression model of the clinical response to 5-fluorouracil based chemotherapy for metastatic colorectal cancer patients.
Hélène Rabinovitch-Chable, Karine Durand, Dominique Genet, Benoît Marin, Hélène Dzugan

Anticancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
Sylvie Giacchetti, Georg Bjarnason, Carlo Garufi, Dominique Genet, Stefano Iacobelli

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
David Planchard, Hugues Bourgeois, Michèle Adoun, Jean-François Paitel, Pierre Blanc, Dominique Genet

Am J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples.
Karine Durand-Faucher, Hélène Rabinovitch-Chable, Hélène Dzugan, Stéphane Charret, Karine Aubry, Dominique Genet

Clin Chem Lab Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
Dominique Genet, D Cupissol, G Calais, P Bontemps, H Bourgeois

Am J Clin Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic complications of implanted central venous access devices: prospective evaluation.
Jean-Luc Labourey, Philippe Lacroix, Dominique Genet, François Gobeaux, Jean Martin

Bull Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis